Stefano Uccella1, Maria Cristina Mele2, Lorena Quagliozzi3, Emanuele Rinninella4, Camilla Nero5, Serena Cappuccio5, Marco Cintoni2, Antonio Gasbarrini6, Giovanni Scambia7, Anna Fagotti7. 1. Department of Woman and Child Health, Fondazione Policlinico Agostino Gemelli, Rome, Italy. Electronic address: stefucc@libero.it. 2. Clinical Nutrition Unit, Gastroenterology Area, Fondazione Policlinico Agostino Gemelli, Catholic University of Sacred Heart, Rome, Italy. 3. Department of Woman and Child Health, Fondazione Policlinico Agostino Gemelli, Rome, Italy. 4. Clinical Nutrition Unit, Gastroenterology Area, Fondazione Policlinico Agostino Gemelli, Catholic University of Sacred Heart, Rome, Italy; Internal Medicine and Gastroenterology Unit, Gastroenterology Area, Fondazione Policlinico Agostino Gemelli, Catholic University of Sacred Heart, Rome, Italy. 5. Department of Woman and Child Health, Fondazione Policlinico Agostino Gemelli - Catholic University of Sacred Heart, Rome, Italy. 6. Internal Medicine and Gastroenterology Unit, Gastroenterology Area, Fondazione Policlinico Agostino Gemelli, Catholic University of Sacred Heart, Rome, Italy. 7. Department of Woman and Child Health, Fondazione Policlinico Agostino Gemelli, Rome, Italy; Department of Woman and Child Health, Fondazione Policlinico Agostino Gemelli - Catholic University of Sacred Heart, Rome, Italy.
Abstract
OBJECTIVE: To investigate whether patients' altered body composition (measured with bioimpedentiometry), due to a poor nutritional status, predicts the incidence of no residual disease at primary debulking and the risk of complications in patients with newly-diagnosed advanced epithelial ovarian cancer (EOC). METHODS: Data regarding patients with newly-diagnosed stage IIIC-IV EOC undergoing elective nutritional assessment between December 2016 and March 2017, were prospectively collected. Bioelectrical impedance analysis (BIA) with measurement of BIA-derived phase angle [PhA] at 50KHz, was accomplished. Only patients with disease which was considered resectable at staging laparoscopy were submitted to open primary cytoreduction. The rate of residual tumor (RT)=0 and the incidence of complications were assessed. RESULTS: Seventy patients were included. Fifty-two of them were submitted to primary cytoreduction (74.3%) and 48 (68.6% of the entire cohort, 92.3% of those who underwent primary debulking) had RT=0 at the end of surgery. Median values of PhA were significantly lower in patients with RT>vs. =0 (4.7, range: 3.6-5.8 vs. 5.3, range: 4.2-6.8; p=0.001). Twenty-four (out of the 52 operated) patients (46.2%) developed at least one complication. PhA was significantly lower in patients with vs. without complications (5, range: 3.6-6.4, vs. 5.4, range 4.5-6.8; p=0.03). After multivariable analysis, Fagotti score and PhA were the only independent predictors of residual disease (OR:13.56; 95%CI:1.33-137.6; p=0.027 and 9.24; 1.16-73.43; p=0.036, respectively) and of any complication (OR:4.9;95%CI:1.17-20.6; p=0.03 and 7.27; 1.45-36.4; p=0.01, respectively). CONCLUSIONS: Derangement of body composition (likely due to disease-related malnutrition) expressed as a low phase angle, is an independent predictor of residual disease and peri-operative complications at the time of upfront cytoreduction for advanced EOC.
OBJECTIVE: To investigate whether patients' altered body composition (measured with bioimpedentiometry), due to a poor nutritional status, predicts the incidence of no residual disease at primary debulking and the risk of complications in patients with newly-diagnosed advanced epithelial ovarian cancer (EOC). METHODS: Data regarding patients with newly-diagnosed stage IIIC-IV EOC undergoing elective nutritional assessment between December 2016 and March 2017, were prospectively collected. Bioelectrical impedance analysis (BIA) with measurement of BIA-derived phase angle [PhA] at 50KHz, was accomplished. Only patients with disease which was considered resectable at staging laparoscopy were submitted to open primary cytoreduction. The rate of residual tumor (RT)=0 and the incidence of complications were assessed. RESULTS: Seventy patients were included. Fifty-two of them were submitted to primary cytoreduction (74.3%) and 48 (68.6% of the entire cohort, 92.3% of those who underwent primary debulking) had RT=0 at the end of surgery. Median values of PhA were significantly lower in patients with RT>vs. =0 (4.7, range: 3.6-5.8 vs. 5.3, range: 4.2-6.8; p=0.001). Twenty-four (out of the 52 operated) patients (46.2%) developed at least one complication. PhA was significantly lower in patients with vs. without complications (5, range: 3.6-6.4, vs. 5.4, range 4.5-6.8; p=0.03). After multivariable analysis, Fagotti score and PhA were the only independent predictors of residual disease (OR:13.56; 95%CI:1.33-137.6; p=0.027 and 9.24; 1.16-73.43; p=0.036, respectively) and of any complication (OR:4.9;95%CI:1.17-20.6; p=0.03 and 7.27; 1.45-36.4; p=0.01, respectively). CONCLUSIONS: Derangement of body composition (likely due to disease-related malnutrition) expressed as a low phase angle, is an independent predictor of residual disease and peri-operative complications at the time of upfront cytoreduction for advanced EOC.
Authors: Emanuele Rinninella; Marco Cintoni; Antonino De Lorenzo; Giovanni Addolorato; Gabriele Vassallo; Rossana Moroni; Giacinto Abele Donato Miggiano; Antonio Gasbarrini; Maria Cristina Mele Journal: Intern Emerg Med Date: 2018-05-30 Impact factor: 3.397
Authors: Shengnan Zhou; Zhangping Yu; Xiaodong Shi; Huaiyu Zhao; Menghua Dai; Wei Chen Journal: Int J Environ Res Public Health Date: 2022-05-25 Impact factor: 4.614
Authors: Barbara Costantini; Virginia Vargiu; Francesco Santullo; Andrea Rosati; Matteo Bruno; Valerio Gallotta; Claudio Lodoli; Rossana Moroni; Fabio Pacelli; Giovanni Scambia; Anna Fagotti Journal: Ann Surg Oncol Date: 2022-04-18 Impact factor: 4.339
Authors: Maurizio Cardi; Simone Sibio; Francesco Di Marzo; Francesco Lefoche; Claudia d'Agostino; Giovanni Battista Fonsi; Giuseppe La Torre; Ludovica Carbonari; Paolo Sammartino Journal: Gastroenterol Res Pract Date: 2019-05-02 Impact factor: 2.260
Authors: Jorne Ubachs; Janine Ziemons; Iris J G Minis-Rutten; Roy F P M Kruitwagen; Jos Kleijnen; Sandrina Lambrechts; Steven W M Olde Damink; Sander S Rensen; Toon Van Gorp Journal: J Cachexia Sarcopenia Muscle Date: 2019-08-07 Impact factor: 12.910